Therapeutic potential of [ 177 Lu]Lu-DOTAGA-FAPi dimers in metastatic breast cancer patients with limited treatment options: efficacy and safety assessment.
Madhav P YadavSanjana BallalMarcel MartinFrank RoeschSwayamjeet SatapathyEuy S MoonMadhavi TripathiAjay GogiaChandrasekhar BalPublished in: European journal of nuclear medicine and molecular imaging (2023)
Lu]Lu-DOTAGA.FAPi dimer treatment demonstrated promising efficacy in patients with advanced breast cancer, as indicated by high disease control rates, favorable response outcomes, and acceptable safety profile. Further research and longer follow-up are warranted to assess long-term outcomes and validate these findings.